Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan E Shepherd

Showing results (171-180 of 252) with videos related to

Pageof 26
Sort By:
BMC Medical Research Methodology|March 27, 2026
Semiparametric outcome regression-based estimator of Mann-Whitney-type causal effectSafiya S Sani, Bryan S Blette, Chun Li, et al.
Journal of the International AIDS Society|March 24, 2018
Virologic failure and mortality in older ART initiators in a multisite Latin American and Caribbean CohortGabriela Carriquiry, Mark J Giganti, Jessica L Castilho, et al.
Journal of the International AIDS Society|April 12, 2016
Assessing the HIV Care Continuum in Latin America: progress in clinical retention, cART use and viral suppressionPeter F Rebeiro, Carina Cesar, Bryan E Shepherd, et al.
The Lancet. HIV|November 2, 2015
Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in the Latin America and the Caribbean: an observational cohort studyCarina Cesar, Cathy A Jenkins, Bryan E Shepherd, et al.
Plos One|June 27, 2017
A decade of HAART in Latin America: Long term outcomes among the first wave of HIV patients to receive combination therapyMarcelo J Wolff, Mark J Giganti, Claudia P Cortes, et al.
Plos One|June 9, 2016
Time to HAART Initiation after Diagnosis and Treatment of Opportunistic Infections in Patients with AIDS in Latin AmericaBrenda Crabtree-Ramírez, Yanink Caro-Vega, Bryan E Shepherd, et al.
Open Forum Infectious Diseases|March 13, 2018
Durability of Efavirenz Compared With Boosted Protease Inhibitor-Based Regimens in Antiretroviral-Naïve Patients in the Caribbean and Central and South AmericaYanink Caro-Vega, Pablo F Belaunzarán-Zamudio, Brenda E Crabtree-Ramírez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 12, 2009
Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the CaribbeanSuely H Tuboi, Mauro Schechter, Catherine C McGowan, et al.
Journal of the International AIDS Society|September 8, 2022
Contraceptive implant use duration is not associated with breakthrough pregnancy among women living with HIV and using efavirenz: a retrospective, longitudinal analysisRandy M Stalter, Gustavo Amorim, A Rain Mocello, et al.
AIDS (London, England)|May 17, 2011
Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban settingC William Wester, John R Koethe, Bryan E Shepherd, et al.
Pageof 26

Showing results (171-180 of 252) with videos related to

Sort By:
Pageof 26
BMC Medical Research Methodology|March 27, 2026
Semiparametric outcome regression-based estimator of Mann-Whitney-type causal effectSafiya S Sani, Bryan S Blette, Chun Li, et al.
Journal of the International AIDS Society|March 24, 2018
Virologic failure and mortality in older ART initiators in a multisite Latin American and Caribbean CohortGabriela Carriquiry, Mark J Giganti, Jessica L Castilho, et al.
Journal of the International AIDS Society|April 12, 2016
Assessing the HIV Care Continuum in Latin America: progress in clinical retention, cART use and viral suppressionPeter F Rebeiro, Carina Cesar, Bryan E Shepherd, et al.
The Lancet. HIV|November 2, 2015
Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in the Latin America and the Caribbean: an observational cohort studyCarina Cesar, Cathy A Jenkins, Bryan E Shepherd, et al.
Plos One|June 27, 2017
A decade of HAART in Latin America: Long term outcomes among the first wave of HIV patients to receive combination therapyMarcelo J Wolff, Mark J Giganti, Claudia P Cortes, et al.
Plos One|June 9, 2016
Time to HAART Initiation after Diagnosis and Treatment of Opportunistic Infections in Patients with AIDS in Latin AmericaBrenda Crabtree-Ramírez, Yanink Caro-Vega, Bryan E Shepherd, et al.
Open Forum Infectious Diseases|March 13, 2018
Durability of Efavirenz Compared With Boosted Protease Inhibitor-Based Regimens in Antiretroviral-Naïve Patients in the Caribbean and Central and South AmericaYanink Caro-Vega, Pablo F Belaunzarán-Zamudio, Brenda E Crabtree-Ramírez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 12, 2009
Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the CaribbeanSuely H Tuboi, Mauro Schechter, Catherine C McGowan, et al.
Journal of the International AIDS Society|September 8, 2022
Contraceptive implant use duration is not associated with breakthrough pregnancy among women living with HIV and using efavirenz: a retrospective, longitudinal analysisRandy M Stalter, Gustavo Amorim, A Rain Mocello, et al.
AIDS (London, England)|May 17, 2011
Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban settingC William Wester, John R Koethe, Bryan E Shepherd, et al.
Pageof 26